The stock of Mangoceuticals Inc (MGRX) has gone down by -2.56% for the week, with a 23.24% rise in the past month and a 49.64% rise in the past quarter. The volatility ratio for the week is 12.32%, and the volatility levels for the past 30 days are 12.11% for MGRX. The simple moving average for the past 20 days is 20.51% for MGRX’s stock, with a 9.35% simple moving average for the past 200 days.
Is It Worth Investing in Mangoceuticals Inc (NASDAQ: MGRX) Right Now?
The 36-month beta value for MGRX is at 1.95.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MGRX is 13.97M, and currently, shorts hold a 0.89% of that float. The average trading volume for MGRX on July 24, 2024 was 5.65M shares.
MGRX) stock’s latest price update
Mangoceuticals Inc (NASDAQ: MGRX)’s stock price has gone rise by 14.20 in comparison to its previous close of 0.37, however, the company has experienced a -2.56% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-07-18 that DALLAS, TEXAS, July 18, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the areas of erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies, is pleased to announce that its CEO, Jacob Cohen, was recently featured on Benzinga All-Access.
MGRX Trading at 19.61% from the 50-Day Moving Average
After a stumble in the market that brought MGRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.65% of loss for the given period.
Volatility was left at 12.11%, however, over the last 30 days, the volatility rate increased by 12.32%, as shares surge +26.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +55.19% upper at present.
During the last 5 trading sessions, MGRX fell by -2.56%, which changed the moving average for the period of 200-days by -34.53% in comparison to the 20-day moving average, which settled at $0.3521. In addition, Mangoceuticals Inc saw 51.32% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MGRX starting from Hamilton Alex P., who sale 108,426 shares at the price of $0.32 back on Jun 26 ’24. After this action, Hamilton Alex P. now owns 50,000 shares of Mangoceuticals Inc, valued at $34,696 using the latest closing price.
Hamilton Alex P., the Director of Mangoceuticals Inc, sale 16,574 shares at $0.31 during a trade that took place back on Jun 25 ’24, which means that Hamilton Alex P. is holding 158,426 shares at $5,138 based on the most recent closing price.
Stock Fundamentals for MGRX
Current profitability levels for the company are sitting at:
- -10.68 for the present operating margin
- 0.62 for the gross margin
The net margin for Mangoceuticals Inc stands at -10.68. The total capital return value is set at 9.91. Equity return is now at value -630.54, with -408.41 for asset returns.
Based on Mangoceuticals Inc (MGRX), the company’s capital structure generated -0.26 points at debt to capital in total, while cash flow to debt ratio is standing at -30.78. The debt to equity ratio resting at -0.21. The interest coverage ratio of the stock is 5129.2.
Currently, EBITDA for the company is -9.19 million with net debt to EBITDA at -0.02. When we switch over and look at the enterprise to sales, we see a ratio of 12.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.07.
Conclusion
In conclusion, Mangoceuticals Inc (MGRX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
